Ascentage Pharma Revenue
Biotechnology Research • 
218 Xinghu Street, Building B7, China • 101-200 Employees
Ascentage Pharma revenue & valuation
| Annual revenue | $13,500,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $43,000,000 |
| Total funding | $417,300,000 |
Key Contacts at Ascentage Pharma
Dr Mohammad Ahmad
Sr Director, Pv And Safety Global Safety Lead
Lu Zhang
Director Business Development
Freesia Chen
Executive Supply Chain Director （Commercial&Clinical）
Parastoo Karoon
Senior Director
Carol Lee
Executive Director, Global Clinical Supplies | Clinical Program Management
Shun Xiao
Sr. Director
Ahmed Faisal
Director, Clinical Operations
Matthew Carney
Senior Director, Head Of Global Data Management
Marcin Mazurek
Associate Director, Project Managment
Manal Tawashi
Executive Director, Clinical Operations
Company overview
| Headquarters | 218 Xinghu Street, Building B7, 7th Floor, Suzhou Industrial Park, Suzhou, China, and Rockville, Maryland, United States, CN |
| Phone number | +8651285557777 |
| Websites | |
| NAICS | 541714 |
| Keywords | BD, Biotech, Pharma, Life Sciences, R&D, Clinical Operations, Hematology, Oncology, Drug Development, Pharmaceutical Manufacturing |
| Founded | 2009 |
| Employees | 101-200 |
| Socials |
Ascentage Pharma Email Formats
Ascentage Pharma uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@ascentage.com), used 71.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@ascentage.com | 72.7% |
{first initial}.{last name} | j.doe@ascentage.com | 23.4% |
{first initial}{last name} | jdoe@ascentagepharma.com | 2.6% |
{last name} | doe@ascentage.com | 1.3% |
About Ascentage Pharma
Ascentage Pharma is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies and is in the process of conducting more than 40 clinical trials in specific regions worldwide. Ascentage Pharma has been listed on the Main Board of the HKEX with the stock code 6855.HK since October 2019 and recently listed in NASDAQ in January 2025 under the stock code AAPG.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Ascentage Pharma has 62 employees across 12 departments.
Departments
Number of employees
Funding Data
Explore Ascentage Pharma's funding history, including investment rounds, total capital raised, and key backers.
Canada
Spain
Frequently asked questions
4.8
40,000 users
